When analyzed in relation to cell cycle parameters, significantly higher ((P<0.05) frequency of patients (80.0%) with aneuploid tumour showed cyclin D1 immunoreactivity (Table) as compared to those with diploid tumours (50%). Here, CCND1 is linked to neoplasm.